Novel Triple Agonist Nabs Biggest Weight Loss Yet in Obesity Trial Plus, two other studies on retatrutide show benefit in type 2 diabetes, fatty liver disease Jun 26, 2023
Bempedoic Acid Gets 'Huge' Win for Primary Prevention in the Statin-Intolerant More positive results in CLEAR Outcomes sub-analysis Jun 26, 2023
Once-Weekly Insulin Icodec Bests Daily Insulin Options for Type 2 Diabetes Superior to once-a-day insulin glargine U100 and degludec Jun 25, 2023
Near 15% Weight Loss With Novel Oral GLP-1 RA in Phase II Obesity Trial Daily orforglipron also lowered HbA1c in type 2 diabetes Jun 24, 2023
Novel Agent Leads to Fibrosis Improvement in NASH Phase IIb ENLIVEN trial saw success with various doses of pegozafermin Jun 24, 2023
First SGLT2 Inhibitor Approved for Kids With Type 2 Diabetes Now another oral option other than metformin Jun 21, 2023
Wide Variation in CGM Settings for Kids With Diabetes Signals Education Gaps Researcher warns of "alarm fatigue" if thresholds aren't optimized to patient Jun 20, 2023
Type 2 Diabetes Cases in Kids Still Rising After 'Return to Normal' Once they returned to school, we thought things would normalize, researcher says Jun 20, 2023
Early Time-Restricted Eating Cut Blood Sugar Fluctuations in Prediabetes Effects in small study seen independent of weight loss Jun 18, 2023
Could Semaglutide Help Curb Addictive Behaviors? Many unanswered questions should elicit attention and caution, experts say Jun 02, 2023
Anti-VEGF Injections for Diabetic Retinopathy Linked to Systemic Adverse Events But question of associated adverse effects is still far from settled, editorialist says Jun 02, 2023
Is Berberine Really 'Nature's Ozempic'? An obesity medicine specialist shares his insights on the new social media craze Jun 02, 2023
More Evidence Backs Gout Benefit for Gliflozin Agents New study finds marked risk reduction tied to drugs' urate-lowering effect Jun 02, 2023
FDA Warns on Certain Forms of Compounded Semaglutide Some products may not contain the same active ingredient as the approved drugs Jun 01, 2023
Sotagliflozin Gets FDA's Blessing for Heart Failure SGLT1/SGLT2 inhibitor approved on the basis of SOLOIST-WHF, SCORED trials May 27, 2023
Oral Semaglutide Sheds Pounds; USPSTF Taking Obesity Comments; Plant Extract for T2D News and commentary from the endocrinology world May 23, 2023
Obesity Drug's Mid-Stage Win; Endocrine Disease Disparities; Chewing Away Diabetes? News and commentary from the endocrinology world May 16, 2023
Topical Esmolol Gel Helped Heal Diabetic Foot Ulcers Significantly better than standard of care at 12 and 24 weeks May 15, 2023
Senators Call Out PBMs, Drugmakers for High Prescription Drug Costs This "is a moral issue," Sen. Bernie Sanders said during the hearing May 11, 2023
Novel Drug Fails to Improve Diabetic Retinopathy, but Slows Progression Significantly fewer patients had 3-step worsening of DRSS with oral antiangiogenic May 09, 2023
Adding This New Criteria Drastically Cut 72-Hour Insulinoma Fast Time Beta-hydroxybutyrate-based stopping point reduced burden on patients May 08, 2023
GLP-1 Agonists Come Out on Top in Cardiovascular Comparison of Newer Diabetes Meds Serious limitations noted of attempt to compare GLP-1 agonists, SGLT-2 inhibitors, however May 08, 2023
GLP-1 RAs Safe Months After Kidney Transplant Helped diabetics cut down on daily insulin dose, body weight May 08, 2023
Is Electrical Duodenal Resurfacing the Next Big Thing for T2D and Obesity? Small trials show big boost in insulin sensitivity, plus weight loss May 07, 2023
Vascular Complications Big Contributor to Diabetes Deaths Diabetic nephropathy was most common of the fatal complications, study showed May 05, 2023
Patients Shed 15% of Body Weight With Tirzepatide, Drugmaker Says With findings from SURMOUNT-2, Eli Lilly plans to finish FDA submission Apr 27, 2023
Bariatric-Metabolic Surgery More Effective Than Lifestyle Change for NASH Roux-en-Y bypass or sleeve gastrectomy resolved NASH without exacerbating liver fibrosis Apr 26, 2023
Weight Loss Giants Going Head-to-Head; FDA OKs Omnipod GO; GLP-1 Drugs for Wolfram? News and commentary from the endocrinology world Apr 25, 2023
New Reader for FreeStyle Libre 3; COVID Bumps Diabetes Risk; Tepezza Label Expanded News and commentary from the endocrinology world Apr 18, 2023
'Relaxed' A1c OK for Mitigating Dementia Risk in Older Diabetes Patients Keeping most readings under 9% avoided elevated dementia risk Apr 17, 2023
Common Diuretic Pauses Atherosclerosis in CKD, T2D If finerenone isn't available, try spironolactone, said researcher Apr 15, 2023
Certain Painkillers Linked to Heart Failure in Type 2 Diabetes Population-based study shows older patients with poorly controlled diabetes at particular risk Apr 10, 2023
Diabetes Patient Develops Large Blisters, Macules on Lower Leg Is infection, injury, or diabetic dermopathy responsible? Apr 10, 2023
Physicians Struggle to Help Diabetes Patients Get Tirzepatide Popular drug faces supply problems and increased demand Apr 07, 2023
Can COVID Lead to Diabetes? Early work suggests a connection, but experts say more investigation is needed Mar 29, 2023
Higher Rybelsus Doses More Effective; Insulin Cap for All? Win for GLP-1/GIP Drug News and commentary from the endocrinology world Mar 28, 2023
Reversing Prediabetes Alone Doesn't Cut Mortality Risk Reduced risk only seen in physically active patients, Taiwanese study found Mar 28, 2023
Fresh Produce Is an Increasingly Popular Prescription for Chronically Ill Patients But do these initiatives work? Mar 26, 2023
Ozempic Back on Shelves; More Positive Fezolinetant Data; Caffeine Cuts Fat? News and commentary from the endocrinology world Mar 21, 2023
Why Does Insulin Cost So Much? Big Pharma Isn't the Only Player Driving Prices Casting a light on profiteering methods of price mediators Mar 12, 2023